Regulation of DNA polymerase POLD4 influences genomic instability in lung cancer
- PMID: 20861182
- DOI: 10.1158/0008-5472.CAN-10-0784
Regulation of DNA polymerase POLD4 influences genomic instability in lung cancer
Abstract
Genomic instability is an important factor in cancer susceptibility, but a mechanistic understanding of how it arises remains unclear. We examined hypothesized contributions of the replicative DNA polymerase δ (pol δ) subunit POLD4 to the generation of genomic instability in lung cancer. In examinations of 158 lung cancers and 5 mixtures of 10 normal lungs, cell cycle- and checkpoint-related genes generally showed mRNA expression increases in cancer, whereas POLD4 showed reduced mRNA in small cell lung cancer (SCLC). A fraction of non-small cell lung cancer patients also showed low expression comparable with that in SCLC, which was associated with poor prognosis. The lung cancer cell line ACC-LC-48 was found to have low POLD4 expression, with higher histone H3K9 methylation and lower acetylation in the POLD4 promoter, as compared with the A549 cell line with high POLD4 expression. In the absence of POLD4, pol δ exhibited impaired in vitro DNA synthesis activity. Augmenting POLD4 expression in cells where it was attenuated altered the sensitivity to the chemical carcinogen 4-nitroquinoline-1-oxide. Conversely, siRNA-mediated reduction of POLD4 in cells with abundant expression resulted in a cell cycle delay, checkpoint activation, and an elevated frequency of chromosomal gap/break formation. Overexpression of an engineered POLD4 carrying silent mutations at the siRNA target site rescued these phenotypes, firmly establishing the role of POLD4 in these effects. Furthermore, POLD4 overexpression reduced intrinsically high induction of γ-H2AX, a well-accepted marker of double-stranded DNA breaks. Together, our findings suggest that reduced expression of POLD4 plays a role in genomic instability in lung cancer.
©2010 AACR.
Similar articles
-
Tumor cell kill by c-MYC depletion: role of MYC-regulated genes that control DNA double-strand break repair.Cancer Res. 2010 Nov 1;70(21):8748-59. doi: 10.1158/0008-5472.CAN-10-0944. Epub 2010 Oct 12. Cancer Res. 2010. PMID: 20940401
-
Epigenetic modulation of tumor suppressor CCAAT/enhancer binding protein alpha activity in lung cancer.J Natl Cancer Inst. 2006 Mar 15;98(6):396-406. doi: 10.1093/jnci/djj093. J Natl Cancer Inst. 2006. PMID: 16537832
-
Aberrant expression and mutation-inducing activity of AID in human lung cancer.Ann Surg Oncol. 2011 Jul;18(7):2084-92. doi: 10.1245/s10434-011-1568-8. Epub 2011 Feb 3. Ann Surg Oncol. 2011. PMID: 21290192
-
DNA methylation and nonsmall cell lung cancer.Anat Rec (Hoboken). 2011 Nov;294(11):1787-95. doi: 10.1002/ar.21471. Epub 2011 Sep 28. Anat Rec (Hoboken). 2011. PMID: 21956844 Review.
-
Pold4, the fourth subunit of replicative polymerase δ, suppresses gene conversion in the immunoglobulin-variable gene in avian DT40 cells.DNA Repair (Amst). 2021 Apr;100:103056. doi: 10.1016/j.dnarep.2021.103056. Epub 2021 Feb 1. DNA Repair (Amst). 2021. PMID: 33588156 Review.
Cited by
-
POLD4 Promotes Glioma Cell Proliferation and Suppressive Immune Microenvironment: A Pan-Cancer Analysis Integrated with Experimental Validation.Int J Mol Sci. 2023 Sep 10;24(18):13919. doi: 10.3390/ijms241813919. Int J Mol Sci. 2023. PMID: 37762224 Free PMC article.
-
LASP1, CERS6, and Actin Form a Ternary Complex That Promotes Cancer Cell Migration.Cancers (Basel). 2023 May 16;15(10):2781. doi: 10.3390/cancers15102781. Cancers (Basel). 2023. PMID: 37345118 Free PMC article.
-
POLD2 is activated by E2F1 to promote triple-negative breast cancer proliferation.Front Oncol. 2022 Sep 2;12:981329. doi: 10.3389/fonc.2022.981329. eCollection 2022. Front Oncol. 2022. PMID: 36119494 Free PMC article.
-
DNA damage repair gene signature model for predicting prognosis and chemotherapy outcomes in lung squamous cell carcinoma.BMC Cancer. 2022 Aug 8;22(1):866. doi: 10.1186/s12885-022-09954-x. BMC Cancer. 2022. PMID: 35941578 Free PMC article.
-
A 17-Gene Expression Signature for Early Identification of Poor Prognosis in Clear Cell Renal Cell Carcinoma.Cancers (Basel). 2021 Dec 30;14(1):178. doi: 10.3390/cancers14010178. Cancers (Basel). 2021. PMID: 35008342 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous